Safe Pregnancies with Rheumatic Diseases are Possible with Planning
source: pixabay.com

Safe Pregnancies with Rheumatic Diseases are Possible with Planning

Dr. Lisa Sammaritano from Weill Cornell Medical College has explained a way to lower risks within pregnancy for those with rheumatic diseases. Pregnancy and Rheumatic Diseases Patients who have a…

Continue Reading Safe Pregnancies with Rheumatic Diseases are Possible with Planning
ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment
source: pixabay.com

ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment

Corbus Pharmaceuticals has just announced that participant enrollment for their Phase 3 trial of lenabasum for dermatomyositis has been completed. Dermatomyositis Dermatomyositis (DM) is a rare autoimmune disease. It can…

Continue Reading ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment

Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease

A team of researchers recently evaluated a new biomarker in interstitial lung disease to see whether or not it could predict disease severity and ultimately mortality. The Biomarker Surfactant protein…

Continue Reading Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis
source: pixabay.com

No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis

The medical field has seen many advancements over the past few decades. In particular, treatment for rheumatic diseases has greatly improved. However, states Healio, this is not reflected in patient…

Continue Reading No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis

Myositis Research Could Aid in COVID-19 Vaccine Development

Myositis Myositis is an autoimmune disease that leads to muscle damage. Patients live with chronic disability due to the symptoms of this rare condition. These include skin rashes, pain, weakness, fatigue,…

Continue Reading Myositis Research Could Aid in COVID-19 Vaccine Development
The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis
Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis

  This year, because of COVID-19, many healthcare-related events and symposiums have been moved online. However, that doesn't mean that the insights are any less helpful! In the virtual ACR…

Continue Reading The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis

Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?

According to CNBC, there is a shortage across the country of a very important medication: hydroxychloroquine. This is somewhat unsurprising. After all, the Trump administration has been vocal about the…

Continue Reading Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?

Phase 3 Clinical Trial has been Initiated for Dermatomyositis

Dermatomyositis (DM) is a disease which causes muscle weakness and rashes on the skin. Immunosuppressive drugs are a common treatment prescribed for the condition. Patients may also be given methotrexate, rituximab,…

Continue Reading Phase 3 Clinical Trial has been Initiated for Dermatomyositis
Study Shows Importance of Biobanks For Rare Disease Research
Source: Pixabay.com

Study Shows Importance of Biobanks For Rare Disease Research

Biobanks store biological samples to help scientists research certain diseases. Registries collect information from patients and standardize it, but no samples are stored. Which of these is best for rare…

Continue Reading Study Shows Importance of Biobanks For Rare Disease Research
Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis
stevepb / Pixabay

Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis

New data has been released about the effects of lenabasum, an experimental drug, on patients with systemic sclerosis and dermatomyositis. Corbus, who are developing lenabasum, are planning to present the…

Continue Reading Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis
The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis
Aymanjed / Pixabay

The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

The US Food and Drug Administration has awarded Orphan Drug Designation to the drug lenabasum as a treatment for dermatomyositis. The use of lenabasum for treating this condition, and others,…

Continue Reading The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

Experimental Treatment for Dermatomyositis Fails to Meet Endpoints in Phase 2 Trial

According to a story from globenewswire.com, the biopharmaceutical company Idera Pharmaceuticals recently released the data from its Phase 2 trial for IMO-8400, an investigational product in development for the treatment…

Continue Reading Experimental Treatment for Dermatomyositis Fails to Meet Endpoints in Phase 2 Trial
For Ten Years this Woman Has Avoided Sunlight Because of Dermatomyositis
https://pixabay.com/en/sunset-birds-cloud-sun-sky-red-1625073/

For Ten Years this Woman Has Avoided Sunlight Because of Dermatomyositis

According to Port City Daily, 21-year-old Haley Swanson has been living with dermatomyositis for 10 years. She was diagnosed at age 11 with the autoimmune condition, which means that her…

Continue Reading For Ten Years this Woman Has Avoided Sunlight Because of Dermatomyositis
Close Menu